MicroRNA-92 promotes gastric cancer cell proliferation and invasion through targeting FXR. (Q41412793)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

30 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

MicroRNA-92 promotes gastric cancer cell proliferation and invasion through targeting FXR. (English)

1 reference

30 September 2017

1 reference

Jian-Hua Duan

1

1 reference

30 September 2017

Long Fang

series ordinal

2

1 reference

30 September 2017

publication date

6 August 2014

1 reference

30 September 2017

1 reference

30 September 2017

volume

35

1 reference

30 September 2017

issue

11

1 reference

30 September 2017

page(s)

11013-11019

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-014-2342-x

30 September 2017

exact match

0 references

cites work

Comparative epidemiology of gastric cancer between Japan and China

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

Gastric cancer-molecular and clinical dimensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

Adult-specific functions of animal microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

Diversifying microRNA sequence and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

MicroRNAs in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

MicroRNA profiling: approaches and considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

MicroRNAs in metabolism and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

MicroRNAs and other non-coding RNAs as targets for anticancer drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

Upregulation of microRNA-107 induces proliferation in human gastric cancer cells by targeting the transcription factor FOXO1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

Synergistic growth inhibition of human hepatocellular carcinoma cells by acyclic retinoid and GW4064, a farnesoid X receptor ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

Farnesoid X receptor is essential for normal glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

Nuclear bile acid receptor FXR protects against intestinal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2342-X

MicroRNA-92 regulates cervical tumorigenesis and its expression is upregulated by human papillomavirus-16 E6 in cervical cancer cells

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25095974

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25095974

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25095974

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-014-2342-X

1 reference

Dimensions Publication ID

30 September 2017

1006418922

0 references

1 reference